| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.06 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.08 | 0.06 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.079 | 0.06 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.06 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.083 | 0.06 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |